Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: A prospective placebo-controlled, double-blind randomized trial

American Journal of Gastroenterology

Volumn 96, Issue 6, 2001, Pages 1751-1757

  Pignatelli, Brigitte ^a   Bancel, Brigitte ^b   Plummer, Martin ^b   Toyokuni, Shinya ^b   Patricot, Louis Marc ^b   Ohshima, Hiroshi ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; DOUBLE BLIND PROCEDURE; ENDOSCOPY; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTAGLANDIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STOMACH ANTRUM; STOMACH MUCOSA;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ASPIRIN; BLOOD PLATELETS; CYCLOOXYGENASE 1; DOUBLE-BLIND METHOD; DUODENAL DISEASES; DUODENAL ULCER; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; STOMACH; STOMACH DISEASES; STOMACH ULCER;

EID: 0034972193     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02491-1     Document Type: Article

References (27)

1. Nonsteroidal anti-inflammatory drugs and gastrointestinal disease
2. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans
3. Helicobacter pylori
4. Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin
5. Peptic ulcer bleeding in the elderly: Relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs
6. Ulcer risk factors: Interactions between H. pylori infection, nonsteroidal use, and age
7. Helicobacter pylori and non-steroidal anti-inflammatory drugs: Uncomfortable partners in peptic ulcer disease
8. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers
9. Mucosal erosions in long-term non-steroidal anti-inflammatory drug users: Predisposition to ulceration and relation to Helicobacter pylori
10. Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: A controlled double-blind trial
11. H. pylori infection increases the risk of nonsteroidal anti-inflammatory drug (NSAID)-induced gastro-duodenal ulceration
12. Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance
13. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen
14. Aspirin as an antiplatelet drug
15. The use of aspirin in ischemic heart disease
16. Aspirin as a therapeutic agent in cardiovascular disease
17. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs
18. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: A prospective study
19. Effects of cutaneous aspirin on the human stomach and duodenum
20. Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans
21. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process
22. Aspirin-induced acute gastric mucosal injury is a neutrophil-dependent process in rats
23. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury
24. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development
25. Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans
26. Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury
27. Clinical aspects of genetic variability in Helicobacter pylori